Page 21 - Read Online

Page 16 of 16 Teschke. Hepatoma Res 2019;5:40 I http://dx.doi.org/10.20517/2394-5079.2019.0017

45. Gellert J, Moreno F, Haydn M, Oldiges H, Frenzel H, et al. Decreased hepatotoxicity of dimethylnitrosamine (DMN) following
chronic alcohol consumption. Adv Exp Med Biol 1980;132:237-43.
46. Teschke, R. Effect of chronic alcohol pretreatment on the hepatotoxicity elicited by chlorpromazine, paracetamol, and
dimethylnitrosamine. Biol Approach Alcohol Natl Inst Alcohol Abuse Alcohol Res Monogr 1983;11:170-89.
47. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994;106:1085-105.
48. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19.
49. Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, et al. Alcohol, microbiome, life style influence alcohol and non-alcoholic
organ damage. Exp Mol Pathol 2017;102:162-80.
50. Osna NA, Donohue TM, Kharbanda KK. Alcoholic liver disease: pathogenesis and current management. Alcohol Res 2017;38:147-61.
51. Basra S, Anand BS. Definition, epidemiology and magnitude of alcoholic hepatitis. World J Hepatol 2011;3:108-13.
52. Day CP, James OFW. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998;114:842-4.
53. Teschke R. Alcoholic steatohepatitis (ASH) and acute alcoholic hepatitis (AH): Cascade of events, clinical features, and
pharmacotherapy options. Exp Opin Pharmacother 2018;19:779-93.
54. Fleming KM, Withal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a
cohort study. Aliment Pharmacol Ther 2010;32:1343-50.
55. Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec’s cirrhosis. Influence of alcohol withdrawal, and possible
effects of recent changes in general management of the disease. Am J Med 1968;44:406-20.
56. Martini GA, Teschke R. Alcohol abstinence in alcoholic liver disease. Acta Med Scand 1985;703:185-94.
57. O’Grady JG. Liver transplantation alcohol related liver disease: (Deliberately) stirring a hornet’s nest! Gut 2006;55:1529-31.
58. Matsushita H, Takaki A. Alcohol and the hepatocellular carcinoma. BMJ Open Gastroenterol 2019;6:e000260.
59. Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 2019;70:284-93.
60. Schlageter M, Terracciano LM, D’Angelo S, Sorrentino P. Histopathology of hepatocellular carcinoma. World J Gastroenterol
2014;20:15955-64.
61. Schlageter M, Quagliata L, Matter M, Perrina V, Tornillo L, et al. Clinicopathological features and metastatic pattern of hepatocellular
carcinoma: an autopsy study of 398 patients. Pathobiology 2016;83:301-7.
62. Mezale D, Strumfa I, Vanags A, Kalva A, Balosis D, et al. Diagnostic algorithm of hepatocellular carcinoma: classics and innovations
in radiology and pathology. Intechopen 2018. Available from: https://www.intechopen.com/books/hepatocellular-carcinoma-advances-
in-diagnosis-and-treatment/diagnostic-algorithm-of-hepatocellular-carcinoma-classics-and-innovations-in-radiology-and-pathology
[last accessed on 7 Nov 2019]
63. Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, et al. Oxidative stress in obesity: a critical component in human diseases. Intl
J Mol Sci 2015;16:378-400.
64. Teschke R, Xuan TD. Viewpoint: a contributory role of Shell ginger (Alpinia zerumbet) for human longevity of Okinawa in Japan?

Nutrients 2018;10:166.
65. Mendez-Sanchez N, Cruz-Ramon VC, Ramirez-Perez OL, Hwang JP, BarrancoFragoso B, et al. New aspects of lipotoxicity in
nonalcoholic steatohepatitis. Int J Mol Sci 2018;19:E2034.
66. Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, et al. Hepatocellular carcinoma: management of an increasingly common
problem. Proc (Bayl Univ Med Cent) 2008;21:266-80.
67. Nahon P, Ganne-Carrié N, Trichet JC, Beaugrand M. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Gastroenterol Clin Biol 2010;34:1-7.
68. Anstee QM, Daly AK, Day CP. Genetics of alcoholic liver disease. Semin Liver Dis 2015;35:361-74.
69. Donato F, Tagger A, Gelatti U, Parinello G, Boffetta P, et al. Alcohol and hepatocellular carcinoma: the effect of life-time intake and
hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-31.
70. Péquinot G, Tuyns AJ, Berta JL. Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol 1978;7:113-20.
71. Tuyns AJ, Péquinot G, Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984;13:53-7.
72. Becker U, Deis A, Sorensen TIA, Gronbaeck M, Borch-Johnsen, et al. Prediction of risk of liver disease by alcohol intake, sex, and
age: a prospective population study. Hepatology 1996;23:1025-9.
73. Caballeria J, Frezza M, Hernández-Muñoz R, DiPadova C, Korsten MA, et al. Gastric origin of the first-pass metabolism of ethanol in
humans: effect of gastrectomy. Gastroenterology 1989;97:1205-9.
74. Pavlov CS, Casazza G, Semenistaia M, Nikolova D, Tsochatzis E, et al. Ultrasonography for diagnosis of alcoholic cirrhosis in people
with alcoholic liver disease. Cochrane Database Syst Rev 2016;3:CD011602.
75. Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?
Ultrasonography 2019;38:200-14.
76. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301-14.
77. Cohen JA, Kaplan MM. The SGOT/SGPT ratio an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-8.
78. Teschke R, Neuefeind M, Nishimura M, Strohmeyer G. Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver:
comparison with other liver enzymes in man and rats. Gut 1983;24:625-30.
79. Heckley GA, Jarl J, Asamoah BO, G-Gerdtham U. How the risk of liver cancer changes after alcohol cessation: a review and meta-
analysis of the current literature. BMC Cancer 2011;11:446.
80. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al; Global Burden of Disease Liver Cancer Collaboration. The burden
of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global
burden of disease study 2015. JAMA Oncol 2017;3:1683-91.